MACFARLANE BURNET CENTRE FOR M has a total of 14 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Australia, United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are GUANGDONG FIRST CONDOR BIOTECHNOLOGY CO LTD, SCOTTISH CROP RESEARCH INST and SHENZHEN GENO IMMUNE MEDICAL INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United Kingdom | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Torresi Joseph | 4 |
#2 | Locarnini Stephen Alistair | 4 |
#3 | Anderson David Andrew | 4 |
#4 | Li Fan | 4 |
#5 | Hui Zhuang | 3 |
#6 | Kent Stephen | 1 |
#7 | Crowe Suzanne Mary | 1 |
#8 | Ramshaw Ian Allister | 1 |
#9 | Mak Johnson Chung-Shun | 1 |
#10 | Hill Melissa Kathleen | 1 |
Publication | Filing date | Title |
---|---|---|
AUPQ177299A0 | A method of prophylaxis, treatment and diagnosis | |
WO9950431A1 | Novel retroviral constructs | |
AU6991098A | Immunoreactive antigens of hepatitis E virus | |
GB9714194D0 | Pharmaceuticals | |
GB9614115D0 | Pharmaceuticals | |
GB9513768D0 | Pharmaceuticals | |
AUPN342695A0 | Non-pathogenic strains of HIV-1 and methods for detecting same-II | |
AUPN302195A0 | Non-pathogenic strains of hiv-1 and methods for detecting same | |
AUPM841394A0 | Anti-viral agents and an assay for detecting same | |
AU7734894A | Immunoreactive antigens of hepatitis E virus | |
AUPM296493A0 | Immunoreactive antigens of hepatitis e virus - II |